Acorda Therapeutics Inc Цена / балансовая стоимость
Что обозначает Цена / балансовая стоимость в Acorda Therapeutics Inc?
Цена / балансовая стоимость Acorda Therapeutics Inc является -0.08
Какое определение для Цена / балансовая стоимость?
Отношение рыночной цены акции к её балансовой учётной стоимости представляет собой соотношение между стоимостью акций компании и балансовой стоимостью на акцию.
The price to book ratio, or P/B ratio, is a financial ratio used to compare a company's current market price to its book value. It is also sometimes known as a market to book ratio or price to equity ratio. The calculation of a price to book ratio can be performed in two ways. It can be calculated as the company's market capitalization divided by the company's total book value from its balance sheet. It can also be calculated using per-share values and dividing a company's current share price by the book value per share (i.e. its book value divided by the number of outstanding shares).
The P/B ratio varies between industries. The industries that require more infrastructure capital (for each dollar of profit) will usually trade at P/B ratios much lower than, for example, consulting firms. P/B ratios are commonly used to compare banks, because most assets and liabilities of banks are constantly valued at market values. A higher P/B ratio implies that investors expect management to create more value from a given set of assets, all else equal (and/or that the market value of the firm's assets is significantly higher than their accounting value).
P/B ratios do not, however, directly provide any information on the ability of the firm to generate profits or cash for shareholders. This ratio also gives some idea of whether an investor is paying too much for what would be left if the company went bankrupt immediately. For companies in distress, the book value is usually calculated without the intangible assets that would have no resale value. In such cases, P/B should also be calculated on a "diluted" basis, because stock options may well vest on sale of the company or change of control or firing of management.
Цена / балансовая стоимость компаний в Health Care сектор на NASDAQ по сравнению с Acorda Therapeutics Inc
Что делает Acorda Therapeutics Inc?
acorda therapeutics is a publicly traded (nasdaq: acor) biotechnology company whose mission is to develop therapies that restore neurological function and improve the lives of people with neurological disorders. we started our company in 1995 as a network of scientists, physicians and business people with a common belief that sharing ideas and information could lead to innovative medical advances for people with neurological disorders. we have since evolved into a commercial-stage biotechnology company, successfully developing and commercializing important therapies that advance the care of people affected by neurological conditions. we achieve our goals by: • investing in research and development • collaborating closely with the patient, medical and scientific communities • retaining employees with compassion and commitment acorda has been voted one of the best companies to work for in new york for the past five years in a row, as a result of our dynamic environment, strong corporate
Компании с цена / балансовая стоимость похож на Acorda Therapeutics Inc
- Vardhman Polytex имеет Цена / балансовая стоимость из -0.09
- MGT Capital Investments имеет Цена / балансовая стоимость из -0.08
- LAIX Inc имеет Цена / балансовая стоимость из -0.08
- Imperial Pacific International имеет Цена / балансовая стоимость из -0.08
- AVIC Joy (HK) имеет Цена / балансовая стоимость из -0.08
- Mobile Internet (China) имеет Цена / балансовая стоимость из -0.08
- Acorda Therapeutics Inc имеет Цена / балансовая стоимость из -0.08
- Maptelligent имеет Цена / балансовая стоимость из -0.08
- Deinove SA имеет Цена / балансовая стоимость из -0.08
- Mahanagar Telephone Nigam имеет Цена / балансовая стоимость из -0.08
- Ruixin International имеет Цена / балансовая стоимость из -0.08
- Premier имеет Цена / балансовая стоимость из -0.08
- Clubhouse Media имеет Цена / балансовая стоимость из -0.08